Dr. Ryan Ramaekers
Claim this profileCHI Health Saint Francis
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
3 reported clinical trials
11 drugs studied
Affiliated Hospitals
More about Ryan Ramaekers
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical TrialTreatments Ryan Ramaekers has experience with
- Belantamab Mafodotin
- Lenalidomide
- Dexamethasone
- Bortezomib
- Biospecimen Collection
- Nivolumab
Breakdown of trials Ryan Ramaekers has run
Multiple Myeloma
Plasma Cell Neoplasms
Ovarian Cancer
Esophageal Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ryan Ramaekers specialize in?
Ryan Ramaekers focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Ryan Ramaekers currently recruiting for clinical trials?
No, Ryan Ramaekers is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Ryan Ramaekers has studied deeply?
Yes, Ryan Ramaekers has studied treatments such as Belantamab mafodotin, Lenalidomide, Dexamethasone.
What is the best way to schedule an appointment with Ryan Ramaekers?
Apply for one of the trials that Ryan Ramaekers is conducting.
What is the office address of Ryan Ramaekers?
The office of Ryan Ramaekers is located at: CHI Health Saint Francis, Grand Island, Nebraska 68803 United States. This is the address for their practice at the CHI Health Saint Francis.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.